LLY
Eli Lilly and Company
1,170.10$
+0.5%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -33.5% | +63.6% | +15.8% | -1.6% | -12.5% | +34.4% | +11.7% | -2.4% | -40.1% | +108.0% | +90.7% | |
| – | +3.5% | +4.8% | +4.7% | +2.7% | -23.4% | +7.4% | +16.9% | -1.6% | +0.3% | +15.7% | +13.0% | |
| – | +39.6% | +17.2% | +10.2% | -0.6% | +11.8% | -1.4% | +11.3% | +8.3% | +69.4% | +2.7% | -3.0% | |
| – | -128.7% | – | -4.9% | +192.3% | -78.7% | -141.4% | – | -157.9% | – | – | – | |
| – | -335.6% | – | – | -174.2% | – | – | – | – | – | – | – | |
| – | +3.9% | -32.8% | +98.1% | +39.5% | -55.2% | +49.9% | -7.7% | +32.6% | +197.6% | +13.7% | -6.7% | |
| – | – | -11,813.1% | +20.5% | – | -524.1% | -72.1% | +26.9% | +31.2% | +90.1% | +30.0% | +18.0% | |
| – | +1.2% | +1.5% | +1.6% | +5.5% | +4.2% | +11.5% | +14.9% | +14.5% | +15.1% | +15.0% | +15.0% | |
| – | -6.3% | -19.9% | -50.0% | +1,284.5% | +6.0% | -88.6% | +150.0% | +20.0% | -50.0% | +233.3% | +64.3% | |
| – | -106.9% | – | +20.0% | -124.3% | – | -93.8% | +71.9% | -112.4% | – | +2.9% | -9.6% | |
| – | +1,654.3% | -80.8% | – | -4,240.9% | -60.6% | +35.0% | +31.7% | +30.9% | – | -64.8% | -279.9% | |
| – | -595.7% | – | +113.4% | -25.2% | -487.2% | – | -87.8% | -1,185.2% | – | -40.2% | +789.3% | |
| – | -53.7% | +180.9% | -8.2% | -27.4% | +39.0% | +28.3% | +20.5% | -14.6% | -168.5% | – | +2,065.6% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.